Earnings season is in full swing, with huge numbers of companies having already given their latest numbers to investors, and Herbalife Ltd. (NYSE:HLF) is about to release its quarterly earnings report. The key to making smart investment decisions with stocks releasing their quarter reports is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed, knee-jerk reaction to news that turns out to be exactly the wrong move.
Herbalife has been mired in controversy, as activist investor Bill Ackman accused it of being a pyramid scheme, sending shares plunging. But other money managers have put their money into the bullish camp. Who’ll prove right? Let’s take an early look at what’s been happening with Herbalife over the past quarter and what we’re likely to see in its quarterly report next Tuesday.
Stats on Herbalife
|Analyst EPS Estimate||$1.03|
|Change From Year-Ago EPS||20%|
|Revenue Estimate||$1.05 billion|
|Change From Year-Ago Revenue||18.8%|
|Earnings Beats in Past 4 Quarters||4|
Can Herbalife get healthy again?
Notwithstanding the fireworks surrounding the stock, analysts have been pretty bullish about Herbalife’s earnings prospects. Over the past three months, they’ve raised their consensus forecast on its earnings per share by $0.02, and pushed full-year 2013 estimates up nearly a dime. Yet after a big rebound from its lows, the stock has pretty much gained back all of its losses since mid-November.
In battles like the one Herbalife is fighting, company fundamentals get shoved to the side. Ackman’s allegations go to the core of Herbalife’s business model, essentially questioning whether Herbalife’s own reported figures for product sales are credible in light of competitors’ volumes. In rebuttal, Herbalife management argued that it is just one of many legitimate multilevel marketing operations that rely on a sales force of distributors to sell their products.
Since then, new players have emerged. Value investor Dan Loeb has taken a substantial stock position in Herbalife, and just yesterday, Carl Icahn disclosed taking a nearly 13% stake after having gotten into a shouting match with Ackman on CNBC over the company last month.
What’s interesting is how other stocks throughout the MLM industry have responded to the ongoing battle. Weight-loss specialist Medifast, Inc. (NYSE:MED) and personal-care companies Usana Health Sciences, Inc. (NYSE:USNA) and Nu Skin Enterprises, Inc. (NYSE:NUS) all plunged when the Herbalife accusations went public, indicating fears that Ackman was casting doubt on the entire industry. Since then, Medifast has remained lower, but Nu Skin and Usana gained back much of their lost ground.